ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,147 | -13.0% | 199 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,766 | +27.3% | 199 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,745 | +18.2% | 199 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,168 | -36.6% | 199 | -29.2% | 0.00% | -33.3% |
| Q3 2022 | $5,000 | +25.0% | 281 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $4,000 | -42.9% | 281 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | +40.0% | 281 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $5,000 | -28.6% | 281 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $7,000 | 0.0% | 281 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -53.3% | 281 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $15,000 | +15.4% | 281 | 0.0% | 0.01% | -23.1% |
| Q2 2020 | $13,000 | -27.8% | 281 | -42.9% | 0.01% | +8.3% |
| Q3 2019 | $18,000 | +28.6% | 492 | -5.7% | 0.01% | +33.3% |
| Q2 2019 | $14,000 | 0.0% | 522 | 0.0% | 0.01% | -18.2% |
| Q1 2019 | $14,000 | +27.3% | 522 | -5.1% | 0.01% | +120.0% |
| Q3 2018 | $11,000 | – | 550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |